Recently, randomized controlled trials and guidelines have brought to light the benefits of extending the duration of H. pylori treatment. Below are summaries of guidelines and trials examining the regimens used to manage the infection.
At the recent Annual Scientific Congress of the Malaysian Society of Gastroenterology and Hepatology (GUT 2016), held at Shangri-La Hotel, Kuala Lumpur, an expert from Hong Kong spoke on the role of direct-acting antivirals as well as pan-genotypic agents that are set to revolutionize hepatitis C treatment.
Sorafenib appears to be well-tolerated in patients with hepatocellular carcinoma (HCC), with the subgroup of Child-Pugh B patients having a shorter treatment duration and higher serious adverse event (SAE) incidence, according to the results of a subgroup analysis of GIDEON*.
An expert panel meeting on hepatorenal syndrome (HRS) was recently convened in Kuala Lumpur with the aim of discussing management practices in different hospital settings. Chaired by Professor Sanjiv Mahadeva, consultant gastroenterologist, University Malaya Medical Centre, the meeting saw local and regional experts share HRS cases they have encountered in their practice.
As its name suggests, inflammatory bowel disease (IBD), which encompasses ulcerative colitis and Crohn’s disease, involves chronic inflammation of the digestive tract. IBD is a common disease in the West, afflicting more than 5 million people.2 Although IBD is still rare in Southeast Asia, the incidence appears to be on the rise in Malaysia, with a rate of 0.67 per 100,000 population.3 It is noteworthy that early detection and management of IBD can reduce a significant amount of pain and stress for patients. Thus, general practitioners (GPs), who are experts trained to work in the front line of a healthcare system, play a vital role in reducing the burden of IBD through immediate referral of suspected IBD patients for specialist investigations.
The term probiotic is coined from a peculiar combination of a Latin word pro (meaning in favour of) and a Greek word bios (meaning life) with the intention to convey the idea of being opposite to antibiotic. Following many refinements to its definition, probiotics today refer to live microorganisms taken for health benefits and have in more recent times seen increasing use for various purposes. At a recent symposium, Professor Keya Rani Lahiri discussed the safety and efficacy of the probiotic Bacillus clausii (Enterogermina®, sanofi-aventis) in paediatric diarrhoea.
Renal transplant recipients have a high incidence of hospitalization due to pyelonephritis, according to a Danish population-based cohort study.
Drinking cranberry juice daily decreases the incidence of urinary tract infections (UTIs) which is often treated with antibiotics, suggesting that cranberry juice can reduce antibiotic use.
Professor Nor Azmi Kamaruddin shares about the first published study in the world on the use of a sodium-glucosecotransporter-2 (SGLT-2) inhibitor during the month of Ramadan, which he supervised and some pointers that doctors should keep in mind when prescribing this agent.
In an exclusive interview with MIMS Doctor, a renowned cardiologist from Universiti Teknologi MARA (UiTM), Associate Professor Dr Sazzli Kasim, discussed the burden of myocardial infarction (MI) in Malaysia and shared his perspective on the use of the high-sensitivity troponin I (hsTnI) test, a sensitive troponin assay for the diagnosis of MI.